Webform

What best describes your current professional status? *

Private

Hospital

Academic

Other

What best describes your current professional status? Other

I am a licensed Physician in the United States. *

Yes

No

How many years have you been in practice? *

How many patients do you typically see each month with cystic fibrosis? *

Please rate the extent to which the Symposium met the following objectives. *

Use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent

	1	2	3	4	5
Review the principles of precision medicine as it pertains to CFTR modulation therapeutics.	Review the principles of precision medicine as it pertains to CFTR modulation therapeutics. - 1	Review the principles of precision medicine as it pertains to CFTR modulation therapeutics. - 2	Review the principles of precision medicine as it pertains to CFTR modulation therapeutics. - 3	Review the principles of precision medicine as it pertains to CFTR modulation therapeutics. - 4	Review the principles of precision medicine as it pertains to CFTR modulation therapeutics. - 5
Recognize risk factors and predictors of disease progression in the cystic fibrosis patient.	Recognize risk factors and predictors of disease progression in the cystic fibrosis patient. - 1	Recognize risk factors and predictors of disease progression in the cystic fibrosis patient. - 2	Recognize risk factors and predictors of disease progression in the cystic fibrosis patient. - 3	Recognize risk factors and predictors of disease progression in the cystic fibrosis patient. - 4	Recognize risk factors and predictors of disease progression in the cystic fibrosis patient. - 5
Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis.	Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis. - 1	Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis. - 2	Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis. - 3	Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis. - 4	Evaluate the impact of CFTR modulation therapeutics on disease progression in the patient with cystic fibrosis. - 5
Describe current approaches to effectively manage patients on CFTR modulation therapeutics.	Describe current approaches to effectively manage patients on CFTR modulation therapeutics. - 1	Describe current approaches to effectively manage patients on CFTR modulation therapeutics. - 2	Describe current approaches to effectively manage patients on CFTR modulation therapeutics. - 3	Describe current approaches to effectively manage patients on CFTR modulation therapeutics. - 4	Describe current approaches to effectively manage patients on CFTR modulation therapeutics. - 5

Please rate the faculty on his/her overall teaching ability, overall knowledge, and level of expertise regarding the subject. *

Use the scale: 1=Poor, 2=Fair, 3=Good, 4=Very Good, 5=Excellent

	1	2	3	4	5
J. Stuart Elborn, MD	J. Stuart Elborn, MD - 1	J. Stuart Elborn, MD - 2	J. Stuart Elborn, MD - 3	J. Stuart Elborn, MD - 4	J. Stuart Elborn, MD - 5
Jane Davies, MD	Jane Davies, MD - 1	Jane Davies, MD - 2	Jane Davies, MD - 3	Jane Davies, MD - 4	Jane Davies, MD - 5
Scott Bell, MD	Scott Bell, MD - 1	Scott Bell, MD - 2	Scott Bell, MD - 3	Scott Bell, MD - 4	Scott Bell, MD - 5
Nico Derichs, MD	Nico Derichs, MD - 1	Nico Derichs, MD - 2	Nico Derichs, MD - 3	Nico Derichs, MD - 4	Nico Derichs, MD - 5

Please rate this Symposium. *

Please use the scale: 1=Strongly Disagree, 2=Disagree, 3=Neutral, 4=Agree, 5=Strongly Agree

	1	2	3	4	5
Overall, the activity met my learning needs	Overall, the activity met my learning needs - 1	Overall, the activity met my learning needs - 2	Overall, the activity met my learning needs - 3	Overall, the activity met my learning needs - 4	Overall, the activity met my learning needs - 5
The information presented was without promotional or commercial bias.	The information presented was without promotional or commercial bias. - 1	The information presented was without promotional or commercial bias. - 2	The information presented was without promotional or commercial bias. - 3	The information presented was without promotional or commercial bias. - 4	The information presented was without promotional or commercial bias. - 5
The information presented was scientifically rigorous and evidence based.	The information presented was scientifically rigorous and evidence based. - 1	The information presented was scientifically rigorous and evidence based. - 2	The information presented was scientifically rigorous and evidence based. - 3	The information presented was scientifically rigorous and evidence based. - 4	The information presented was scientifically rigorous and evidence based. - 5
The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A)	The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A) - 1	The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A) - 2	The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A) - 3	The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A) - 4	The information presented provided appropriate and effective opportunities for active learning (discussion, Q&A) - 5
The information presented promoted improvements or quality in healthcare.	The information presented promoted improvements or quality in healthcare. - 1	The information presented promoted improvements or quality in healthcare. - 2	The information presented promoted improvements or quality in healthcare. - 3	The information presented promoted improvements or quality in healthcare. - 4	The information presented promoted improvements or quality in healthcare. - 5
The quality of the educational process was satisfactory and appropriate.	The quality of the educational process was satisfactory and appropriate. - 1	The quality of the educational process was satisfactory and appropriate. - 2	The quality of the educational process was satisfactory and appropriate. - 3	The quality of the educational process was satisfactory and appropriate. - 4	The quality of the educational process was satisfactory and appropriate. - 5
The information provided with regard to faculty relations met my needs for disclosure.	The information provided with regard to faculty relations met my needs for disclosure. - 1	The information provided with regard to faculty relations met my needs for disclosure. - 2	The information provided with regard to faculty relations met my needs for disclosure. - 3	The information provided with regard to faculty relations met my needs for disclosure. - 4	The information provided with regard to faculty relations met my needs for disclosure. - 5
The speakers were knowledgeable and presented the information clearly.	The speakers were knowledgeable and presented the information clearly. - 1	The speakers were knowledgeable and presented the information clearly. - 2	The speakers were knowledgeable and presented the information clearly. - 3	The speakers were knowledgeable and presented the information clearly. - 4	The speakers were knowledgeable and presented the information clearly. - 5
The format of the discussion was relevant and enhanced my knowledge of the subject.	The format of the discussion was relevant and enhanced my knowledge of the subject. - 1	The format of the discussion was relevant and enhanced my knowledge of the subject. - 2	The format of the discussion was relevant and enhanced my knowledge of the subject. - 3	The format of the discussion was relevant and enhanced my knowledge of the subject. - 4	The format of the discussion was relevant and enhanced my knowledge of the subject. - 5
The registration for this meeting was efficient and professional.	The registration for this meeting was efficient and professional. - 1	The registration for this meeting was efficient and professional. - 2	The registration for this meeting was efficient and professional. - 3	The registration for this meeting was efficient and professional. - 4	The registration for this meeting was efficient and professional. - 5

This educational activity will result in a change in my practice behavior. *

Yes

No

N/A

If so, what will you change?

Based on your participation in this activity. *

Choose all statements that apply.

I gained new strategies/skills/information that I can apply to my area of practice

I plan to implement new strategies/skills/information to my practice

I need more information before I can implement new strategies/skills/information into my practice.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

What strategies/changes do you plan to implement in your practice?

What barriers do you see to making a change in your practice?

Would you be willing to participate in a post activity follow-up survey? *

Yes

No

Do you wish to be notified by email when new educational programs are offered by Elsevier? *

Yes

No

Please provide us with suggestions for improving this activity.

Please provide details on any concerns or issues you had with this activity.

How did you hear about this symposium? Other...

Please select the type(s) of credit you plan to claim: *

EACCME credits

EBAP credits

Acknowledgment of participation

You are here